{"id":864652,"date":"2025-06-27T16:05:47","date_gmt":"2025-06-27T20:05:47","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/xenon-joins-the-russell-3000-and-russell-2000-indexes\/"},"modified":"2025-06-27T16:05:47","modified_gmt":"2025-06-27T20:05:47","slug":"xenon-joins-the-russell-3000-and-russell-2000-indexes","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/xenon-joins-the-russell-3000-and-russell-2000-indexes\/","title":{"rendered":"Xenon Joins the Russell 3000\u00ae and Russell 2000\u00ae Indexes"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">VANCOUVER, British Columbia and BOSTON, June  27, 2025  (GLOBE NEWSWIRE) &#8212; Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, today announced that the company has been added to the broad-market Russell 3000\u00ae and small-cap Russell 2000\u00ae Indexes as part of the annual reconstitution, effective at the close of U.S. equity markets on Friday, June 27, 2025.<\/p>\n<p align=\"justify\">The Russell 3000\u00ae Index is an equity index that tracks the performance of the largest 3,000 U.S. stocks by market capitalization. The Russell 2000\u00ae Index measures the performance of the 2,000 smallest companies within the Russell 3000\u00ae Index. Inclusion in the Russell 2000\u00ae results in automatic inclusion in the appropriate growth and value style indexes.<\/p>\n<p align=\"justify\">Russell U.S. Indexes are widely used by investment managers and institutional investors as the basis for index funds and as benchmarks for investment strategies. Approximately $10.6 trillion in assets are benchmarked against Russell U.S. indexes.<\/p>\n<p align=\"justify\">For more information on the Russell 3000\u00ae Index and the Russell indexes reconstitution, go to the \u201cRussell Reconstitution\u201d section on the FTSE Russell website.<\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <u>About Xenon Pharmaceuticals Inc.<\/u><br \/>\n        <\/strong>\n      <\/p>\n<p align=\"justify\">Xenon Pharmaceuticals (Nasdaq: XENE) is a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics. We are advancing an ion channel product portfolio to address areas of high unmet medical need, including epilepsy and depression. Azetukalner, a novel, highly potent, selective Kv7 potassium channel opener, represents the most advanced, clinically validated potassium channel modulator in late-stage clinical development for multiple indications. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=A0JKbt3mWYcrmdlu2KsEnFbr0oEMk6gdfhjSQNmmhA4Vyobjqk__MKhWK7KU1o-h4xonB0Gprj6O36WZO9SlRHxf3_qPUEQT2HrvEnlfIJo=\" rel=\"nofollow\" target=\"_blank\"><u>www.xenon-pharma.com<\/u><\/a>.<\/p>\n<p align=\"justify\">\u201cXenon\u201d and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.<\/p>\n<p align=\"justify\">\n        <strong>Contacts: <\/strong><br \/>\n        <br \/>\n        <em>For Investors:<\/em><br \/>\n        <br \/>Chad Fugere<br \/>Vice President, Investor Relations<br \/>(857) 675-7275<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=V-9xnLgkIqPgf_481Y_-brZ6bH13WkaobImlrbSZTdY7MhNAfB9J8PUsCfIz65FlbI8Aj7HfbyeqAVji1dKPfzgwCnFxYWDISaUip4ZRfd1DN0_bVuUBsZJElnEcxafC\" rel=\"nofollow\" target=\"_blank\">investors@xenon-pharma.com<\/a><\/p>\n<p align=\"justify\">\n        <em>For Media:<\/em><br \/>\n        <br \/>Colleen Alabiso<br \/>Senior Vice President, Corporate Affairs<br \/>(617) 671-9238<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=tQKFHA07cTOUAE8MJnma839D4PDSiVOkx-zSHeiRWgLQXls8YPpNAPuZlYIftoag4WvKWiKczFfNJgZlLarYYwQ2ZW0-4xCGxj69hSAOW8M=\" rel=\"nofollow\" target=\"_blank\">media@xenon-pharma.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4NTkzNyM3MDIyNDc1IzIwMTEzODA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NDIxOWYwOWEtZjRjNy00MzEwLTgzODYtOGI4ZGJjNmI5YWI1LTEwMjI5NTMtMjAyNS0wNi0yNy1lbg==\/tiny\/Xenon-Pharmaceuticals-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>VANCOUVER, British Columbia and BOSTON, June 27, 2025 (GLOBE NEWSWIRE) &#8212; Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, today announced that the company has been added to the broad-market Russell 3000\u00ae and small-cap Russell 2000\u00ae Indexes as part of the annual reconstitution, effective at the close of U.S. equity markets on Friday, June 27, 2025. The Russell 3000\u00ae Index is an equity index that tracks the performance of the largest 3,000 U.S. stocks by market capitalization. The Russell 2000\u00ae Index measures the performance of the 2,000 smallest companies within the Russell 3000\u00ae Index. Inclusion in the Russell 2000\u00ae results in automatic inclusion in the appropriate growth &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/xenon-joins-the-russell-3000-and-russell-2000-indexes\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Xenon Joins the Russell 3000\u00ae and Russell 2000\u00ae Indexes&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-864652","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Xenon Joins the Russell 3000\u00ae and Russell 2000\u00ae Indexes - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/xenon-joins-the-russell-3000-and-russell-2000-indexes\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Xenon Joins the Russell 3000\u00ae and Russell 2000\u00ae Indexes - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"VANCOUVER, British Columbia and BOSTON, June 27, 2025 (GLOBE NEWSWIRE) &#8212; Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, today announced that the company has been added to the broad-market Russell 3000\u00ae and small-cap Russell 2000\u00ae Indexes as part of the annual reconstitution, effective at the close of U.S. equity markets on Friday, June 27, 2025. The Russell 3000\u00ae Index is an equity index that tracks the performance of the largest 3,000 U.S. stocks by market capitalization. The Russell 2000\u00ae Index measures the performance of the 2,000 smallest companies within the Russell 3000\u00ae Index. Inclusion in the Russell 2000\u00ae results in automatic inclusion in the appropriate growth &hellip; Continue reading &quot;Xenon Joins the Russell 3000\u00ae and Russell 2000\u00ae Indexes&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/xenon-joins-the-russell-3000-and-russell-2000-indexes\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-27T20:05:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4NTkzNyM3MDIyNDc1IzIwMTEzODA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/xenon-joins-the-russell-3000-and-russell-2000-indexes\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/xenon-joins-the-russell-3000-and-russell-2000-indexes\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Xenon Joins the Russell 3000\u00ae and Russell 2000\u00ae Indexes\",\"datePublished\":\"2025-06-27T20:05:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/xenon-joins-the-russell-3000-and-russell-2000-indexes\\\/\"},\"wordCount\":304,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/xenon-joins-the-russell-3000-and-russell-2000-indexes\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ4NTkzNyM3MDIyNDc1IzIwMTEzODA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/xenon-joins-the-russell-3000-and-russell-2000-indexes\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/xenon-joins-the-russell-3000-and-russell-2000-indexes\\\/\",\"name\":\"Xenon Joins the Russell 3000\u00ae and Russell 2000\u00ae Indexes - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/xenon-joins-the-russell-3000-and-russell-2000-indexes\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/xenon-joins-the-russell-3000-and-russell-2000-indexes\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ4NTkzNyM3MDIyNDc1IzIwMTEzODA=\",\"datePublished\":\"2025-06-27T20:05:47+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/xenon-joins-the-russell-3000-and-russell-2000-indexes\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/xenon-joins-the-russell-3000-and-russell-2000-indexes\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/xenon-joins-the-russell-3000-and-russell-2000-indexes\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ4NTkzNyM3MDIyNDc1IzIwMTEzODA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ4NTkzNyM3MDIyNDc1IzIwMTEzODA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/xenon-joins-the-russell-3000-and-russell-2000-indexes\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Xenon Joins the Russell 3000\u00ae and Russell 2000\u00ae Indexes\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Xenon Joins the Russell 3000\u00ae and Russell 2000\u00ae Indexes - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/xenon-joins-the-russell-3000-and-russell-2000-indexes\/","og_locale":"en_US","og_type":"article","og_title":"Xenon Joins the Russell 3000\u00ae and Russell 2000\u00ae Indexes - Market Newsdesk","og_description":"VANCOUVER, British Columbia and BOSTON, June 27, 2025 (GLOBE NEWSWIRE) &#8212; Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, today announced that the company has been added to the broad-market Russell 3000\u00ae and small-cap Russell 2000\u00ae Indexes as part of the annual reconstitution, effective at the close of U.S. equity markets on Friday, June 27, 2025. The Russell 3000\u00ae Index is an equity index that tracks the performance of the largest 3,000 U.S. stocks by market capitalization. The Russell 2000\u00ae Index measures the performance of the 2,000 smallest companies within the Russell 3000\u00ae Index. Inclusion in the Russell 2000\u00ae results in automatic inclusion in the appropriate growth &hellip; Continue reading \"Xenon Joins the Russell 3000\u00ae and Russell 2000\u00ae Indexes\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/xenon-joins-the-russell-3000-and-russell-2000-indexes\/","og_site_name":"Market Newsdesk","article_published_time":"2025-06-27T20:05:47+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4NTkzNyM3MDIyNDc1IzIwMTEzODA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/xenon-joins-the-russell-3000-and-russell-2000-indexes\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/xenon-joins-the-russell-3000-and-russell-2000-indexes\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Xenon Joins the Russell 3000\u00ae and Russell 2000\u00ae Indexes","datePublished":"2025-06-27T20:05:47+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/xenon-joins-the-russell-3000-and-russell-2000-indexes\/"},"wordCount":304,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/xenon-joins-the-russell-3000-and-russell-2000-indexes\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4NTkzNyM3MDIyNDc1IzIwMTEzODA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/xenon-joins-the-russell-3000-and-russell-2000-indexes\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/xenon-joins-the-russell-3000-and-russell-2000-indexes\/","name":"Xenon Joins the Russell 3000\u00ae and Russell 2000\u00ae Indexes - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/xenon-joins-the-russell-3000-and-russell-2000-indexes\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/xenon-joins-the-russell-3000-and-russell-2000-indexes\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4NTkzNyM3MDIyNDc1IzIwMTEzODA=","datePublished":"2025-06-27T20:05:47+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/xenon-joins-the-russell-3000-and-russell-2000-indexes\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/xenon-joins-the-russell-3000-and-russell-2000-indexes\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/xenon-joins-the-russell-3000-and-russell-2000-indexes\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4NTkzNyM3MDIyNDc1IzIwMTEzODA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4NTkzNyM3MDIyNDc1IzIwMTEzODA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/xenon-joins-the-russell-3000-and-russell-2000-indexes\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Xenon Joins the Russell 3000\u00ae and Russell 2000\u00ae Indexes"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/864652","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=864652"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/864652\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=864652"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=864652"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=864652"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}